Skip to content
DataLookout
Menu

NCT04737616

Continuous Monitoring and Management of Vaginal Health Via Multifunctional OCT/OCTA/OCE Endoscopy

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 1 month later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jul 2026 to Sep 2027
    • Eligibility criteria expanded, about 5 words
  2. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  3. Notable Primary and study completion dates: Jul 1, 2024 to Jul 2026
    • Study site revised
    • Collaborators expanded, about 5 words
    v4
  4. Notable Primary and study completion dates: Jul 1, 2023 to Jul 1, 2024v3
  5. Notable Primary and study completion dates: Jul 1, 2022 to Jul 1, 2023v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Vaginal epithelial thickness (VET)
Timeframe: 2 years

Secondary (3)

blood vessel density
Vaginal Health Index (VHI)
Lactobacillus abundance

Arms and interventions

CO2 Laser +OCTExperimental

Postmenopausal women with genitourinary syndrome of menopause who will receive CO2 vaginal laser treatment

OCT onlyExperimental

Premenopausal, peri-menopausal and postmenopausal women who will only get one time OCT scan

Devices: CO2 laser, OCT

Sites

1 site in 1 country

  • Beckman Laser Institute and Medical ClinicIrvine, California, United States